Brentuximab vedotin – July 2026

  • Brand names:
    • Adcetris®
  • Pharmaceutical Company:
    • TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.
  • Condition/Indication: Hodgkin lymphoma
  • Meeting Date: July 2026
Public Summary Documents
Last updated
13 November 2026